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Cardiac progenitor cellsMuch of the heart, including the atria, right ventricle and outﬂow tract (OFT) is derived from a progenitor cell
population termed the second heart ﬁeld (SHF) that contributes progressively to the embryonic heart during
cardiac looping. Several studies have revealed anterior-posterior patterning of the SHF, since the anterior
region (anterior heart ﬁeld) contributes to right ventricular andOFTmyocardiumwhereas the posterior region
gives rise to the atria. We have previously shown that Retinoic Acid (RA) signal participates to this patterning.
We now show thatHoxb1,Hoxa1, andHoxa3, as downstream RA targets, are expressed in distinct sub-domains
within the SHF. Our genetic lineage tracing analysis revealed that Hoxb1, Hoxa1 and Hoxa3-expressing cardiac
progenitor cells contribute to both atria and the inferior wall of the OFT, which subsequently gives rise to
myocardium at the base of pulmonary trunk. By contrast to Hoxb1Cre, the contribution of Hoxa1-enhIII-Cre and
Hoxa3Cre-labeled cells is restricted to the distal regions of the OFT suggesting that proximo-distal patterning of
the OFT is related to SHF sub-domains characterized by combinatorial Hox genes expression. Manipulation of
RA signaling pathways showed that RA is required for the correct deployment ofHox-expressing SHF cells. This
report provides new insights into the regulatory gene network in SHF cells contributing to the atria and
sub-pulmonary myocardium.ersité d'Aix-Marseille, Faculté
e. Fax: +33 4 91 79 72 27.
ertrand),
versity of California, San Diego,
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The four-chambered mammalian heart forms from a heteroge-
neous population of progenitor cells in anterior lateral mesoderm.
Studies in mouse and chick have established that the heart forms from
two sources of progenitor cells (Buckingham et al., 2005; Vincent and
Buckingham, 2010). As the embryo grows, cells of the cardiac crescent
fuse at the midline to form the primitive heart tube. The primitive
heart tube initially functions to support the embryonic circulation and
provides a scaffold into which the cells from the second heart ﬁeld
(SHF) migrate prior to chamber morphogenesis. SHF cells are ﬁrstlocated medially to the cardiac crescent, and subsequently reside in
mesoderm underlying the pharynx before they accrue to the heart.
The contribution of this population of cardiac progenitors to the heart
was revealed by studies of the LIM transcription factor Islet1 (Isl1),
which is a pan-marker of the SHF (Cai et al., 2003). The rostral part of
the SHF, the anterior heart ﬁeld (AHF), which is marked by Fgf10
expression (Kelly et al., 2001) contributes to the formation of right
ventricular and outﬂow tract (OFT)myocardium (Zaffran et al., 2004),
whereas cells in the posterior SHF (Cai et al., 2003) expressing Isl1, but
not AHF markers, contribute to atrial myocardium (Galli et al., 2008).
These data indicate that the SHF is patterned along the anterior-
posterior (AP) axis of the mouse embryo, however, a detailed under-
standing of the molecular regulatory pathways governing this process
is lacking.
We have recently shown that the retinoic acid (RA) signaling
pathway plays a potent role in limiting cardiac speciﬁcation. Mouse
embryos lacking the RA synthesis enzyme Raldh2 have an expanded
SHF, resulting in morphogenetic defects at both the arterial and
venous poles (Ryckebusch et al., 2008). Consistent with this, zebraﬁsh
embryos lacking RA signaling exhibit an excess of cardiac progenitor
267N. Bertrand et al. / Developmental Biology 353 (2011) 266–274cells in the lateral mesoderm (Keegan et al., 2005). In the avianmodel,
RA signaling promotes atrial cell identity within the heart ﬁeld
(Xavier-Neto et al., 1999; Xavier-Neto et al., 2001; Hochgreb et al.,
2003). It remains unknown whether the functions of RA signaling
on SHF development and cardiac identity are distinct or overlapping.
Identifying RA-target genes in cardiac progenitor cells will help
to elucidate the mechanisms downstream of RA signaling that delimit
the SHF. Studies in zebraﬁsh embryos demonstrated that Hoxb5b,
expressed in the forelimb ﬁeld, acts downstream of RA signaling
to restrict the number of cardiac progenitor cells (Waxman and
Yelon, 2009). Thus, we hypothesized that some of the homeobox
(Hox) genes may be functional targets of RA in cardiac lineages in the
mouse.
Hox genes are a large family of related genes that encode homeo-
domain transcription factors.MammalianHoxgenes are clustered in four
chromosomal loci (the Hox clusters) and play an important role in
regulating the speciﬁcation of positional identities along the AP axis
during development (Alexander et al., 2009;Wellik, 2009).Within each
cluster, the genes are arranged in a sequence that reﬂects their
sequential activation during development (temporal collinearity)
(Izpisua-Belmonte et al., 1990) and theposition of the anterior boundary
of their expression domains along the AP body axis (spatial collinearity)
(Duboule and Dolle, 1989; Graham et al., 1989). InitialHox transcription
and rostral expansionofHox expressiondomains are regulated inpart by
events that are connected to the emergence and extension of the
primitive streak (Forlani et al., 2003; Iimura and Pourquie, 2006). A
contributionof RA signaling to the initial activation ofHoxexpressionhas
been suggested, since at early developmental stages, embryos with
impaired RA synthesis (Raldh2−/− mutants) exhibit abnormal initial 3'
Hox gene expression domains (Niederreither et al., 1999). Moreover, RA
was shown to regulate embryonic AP patterning, in particular by
controlling theexpressionof speciﬁcHoxgenes (Niederreither andDolle,
2008; Alexander et al., 2009).
In this study, we show that the anterior Hox genes, Hoxb1, Hoxa1
and Hoxa3, are expressed in the SHF as early as embryonic day (E) 7.5
and deﬁne distinct sub-domains in the splanchnic mesoderm. Genetic
(cre-mediated) lineage tracing reveals that Hoxb1, Hoxa1 and Hoxa3-
expressing cardiac progenitor cells give rise to the atria and the
inferior wall of the OFT, which subsequently yields themyocardium at
the base of the pulmonary trunk. Furthermore, Hoxb1IRES-Cre, Hoxa1-
enhIII-Cre and Hoxa3IRES-Cre marked cells shows differential contribu-
tions to the proximal and distal regions of the OFT. Manipulation of
the RA signaling pathway using Raldh2−/− embryos or injection of all-
trans-RA demonstrates that expression of these Hox genes in the SHF
and their cardiac contribution to the heart are sensitive to RA dosage.
Comparison of transgenes expression in Raldh2 mutant embryos
reveals that RA signaling is required for these Hox-expressing cardiac
progenitor cell populations to contribute to the heart.Materials and methods
Mouse lines and breeding
All mouse lines used in this study have been previously described:
Raldh2-null (Niederreither et al., 1999), Hoxa3IRES-Cre (Macatee et al.,
2003), Hoxb1IRES-Cre (Arenkiel et al., 2003) alleles andMlc1v-nlacZ-24/
Fgf10lacZ (Kelly et al., 2001), RARE-hsp68-lacZ (Rossant et al., 1991),
y96-Myf5-nlacZ-16 (96–16), A17-Myf5-nlacZ-T55 (T55) (Bajolle et al.,
2008) and R26R-lacZ (Soriano, 1999) transgenes. Mice were geno-
typed by PCR as described in the original reports. Embryoswere staged
taking embryonic day (E) 0.5 as the morning of the vaginal plug. Cre-
induced recombinationwas analyzed by breeding Cremicewith R26R-
lacZ reporter mice and analyzing embryos with the genotype Cre;
R26R-lacZ by X-gal staining. Animal care was in accordance with
national and institutional guidelines.Generation of novel transgenic line
The Hoxa1 enhancer III-Cre (Hoxa1-enhIII-Cre) construct DNA was
previously described by Li and Lufkin (2000) (Li and Lufkin, 2000).
Transgenic micewere generated bymicroinjection of puriﬁed plasmid
DNA into fertilized (C57BL/6XDBA/2) F2 eggs at a concentration of
approx. 1 ng/μl using standard techniques. Injected eggs were re-
implanted the day after the injection into pseudo-pregnant (C57BL/6),
foster mothers.
X-gal staining, histology and RNA in situ hybridizations
To visualize β-galactosidase activity, embryos or hearts were
isolated, ﬁxed in 4% paraformaldehyde for 20 min and moved into
X-gal solution, according to standard procedures. Embryos or hearts
were photographed (Zeiss Lumar V12 stereomicroscope) as whole-
mount specimens and then embedded in O.C.T. and cut into 12 μM
histological section before being counterstained with eosin.
Whole-mount in situ hybridization (ISH) was performed as
previously described (Ryckebusch et al., 2008). Double whole-mount
ISH with digoxigenin (DIG)- and FITC-labeled riboprobes were
performed according to the Stern laboratory protocol (http://www.
ucl.ac.uk/cdb/research/stern/stern_lab/insitu, Protocols section).
The following riboprobes used in this study were Hoxa1, Hoxb1,
Hoxa2, Hoxa3, islet1, Tbx5, and Raldh2. For single ISH, hybridization
signals were then detected by alkalin phosphatase (AP)-conjugated
anti-DIG antibodies (1/4000; Roche), which were followed by color
development with NBT/BCIP (magenta) substrate (Promega). For
double ISH hybridization signals we used an anti-FITC antibody coupled
to AP (1/4000; Roche), and the NBT-BCIP (magenta) (Promega) for the
ﬁrst detection, and an anti-DIG antibody coupled to AP (1/2000; Roche)
and the INT-BCIP (brick red) (Roche) for the second detection. After
staining, the sampleswerewashed in PBS andpost-ﬁxed. Embryoswere
photographed using a Zeiss Lumar stereomicroscope coupled to an
Axiocam digital camera (AxioVision 4.4, Zeiss). The number of embryos
examined was at least three for each stage.
Immunostaining
Embryos were ﬁxed at 4 °C for 20 min in 4% paraformaldehyde,
rinsed in PBS, equilibrated to 15% sucrose and embedded in O.C.T.
Cryosections were cut at 12 μm, washed in PBS and pre-incubated in
blocking solution (1%BSA, 1% Serum, 0.2% Tween 20 in PBS). Primary
antibodies were applied overnight at 4 °C, followed by secondary
detection using Alexa Fluor conjugated (Molecular Probes) secondary
antibodies. Sections were photographed using Leica DM 5000B
microscope.
The following primary antibodies were used in this study: rabbit
anti-Hoxb1 (Covance; 1/200), rabbit anti-GFP (Invitrogen; 1/500),
rabbit anti-βGal (sigma; 1/500) and mouse anti-Islet1 (DSHB: 1/100).
Retinoic acid treatment of embryos
All-trans-RA (Sigma)wasdissolved inDMSOanddilutedat 20 mg/ml.
At E7.75, the mice were given a single intra-peritoneal injection of RA
(70 mg/kg or 85 mg/kg) or control DMSO. Embryos were later dissected
at E8.5 or E9.5.
Results
Anterior-posterior patterning of the second heart ﬁeld
Wepreviously reported that RA signaling is required to establish the
posterior limit of the second heart ﬁeld (SHF) in splanchnic mesoderm
of mouse embryos (Ryckebusch et al., 2008). However, this study did
not identify the molecules downstream of RA signaling that are
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been suggested to be among the key downstream effectors of RA
signaling during cardiac patterning (Searcy and Yutzey, 1998;Waxman
et al., 2008). Therefore, we examined the expression pattern of several
Hox genes within the lateral mesoderm and compared their expression
to cardiac markers. We selected Hoxb1, Hoxa1 and Hoxa3 because they
are among the ﬁrstHox genes to be activated at the primitive streak and
consequently display anterior limits of expression close to the cardiac
ﬁeld. At E7.25, the expression domains of Hoxb1, Hoxa1 and Hoxa3
overlapped with those of the RA-synthesizing enzyme Raldh2, and the
RARE-lacZ transgene, a reporter for RA activity (Supplemental Fig. S1).
During extension of the primitive streak, transcription ofHoxb1 initiates
earlier than Hoxa1 and Hoxa3 (Supplemental Fig. S1), suggesting that
sequential temporal activation of these Hox genes is important to
establish anterior-posterior (AP) patterning of the lateral mesoderm. At
E7.75, the anterior border ofHoxb1 expression ismore rostral than those
of Hoxa1 and Hoxa3 (Fig. 1A, D, G).
Despite reported expression in early mesodermal cells (Frohman
et al., 1990; Murphy and Hill, 1991), Hox gene expression relative to
the heart ﬁeld has never been explored in the mouse. To assess the
expression of Hox genes in the heart ﬁeld, we performed double in
situ hybridization with Tbx5 and Islet1 (Isl1), which label the cardiac
crescent and the SHF respectively (Fig. 1H, I) (Buckingham et al.,
2005). At the early cardiac crescent stage, Hoxb1 (orange) and Isl1
(purple) exhibit an overlap of their expression domains (compare
Fig. 1A, C and I; arrowheads), suggesting that Hoxb1 is expressed in
cardiac progenitor cells. Embryos double-stained for Hoxb1 and Tbx5
(purple) display no overlap, indicating thatHoxb1 is not expressed in
Tbx5-positive cells (compare Fig. 1A, B and H). Consistent with our
previous observations (Ryckebusch et al., 2008), double labeling
conﬁrms that the Hoxa1 expression domain is adjacent to the
cardiogenic region marked by Tbx5 at E7.75 (Fig. 1E). However, we
detected a small overlap between Hoxa1 and Isl1 in the splanchnicFig. 1. Relation between Hoxb1 and Hoxa1 expression and the heart ﬁelds. (A–F) Hoxb1
and Hoxa1 expression analysis by single and double in situ hybridizations (ISH) on
E7.75 embryos. (G) Hoxa3 expression analysis by ISH. (H, I) Whole-mount ISH with
Tbx5 and Islet1 (Isl1) probes, which mark the cardiac crescent (cc) and the second heart
ﬁeld (SHF) respectively. Insets display a ventral view of same stained embryo. (A, D, G)
At E7.75, Hoxb1, Hoxa1 and Hoxa3 reach their most anterior border of expression near
the cardiac crescent (cc). (B, C) Whole-mount ISH analysis showing that the anterior
border of Hoxb1 expression overlaps with Isl1 (arrowhead in C), but not with Tbx5.
(E, F) Whole-mount ISH analysis showing Hoxa1 expression in an adjacent domain of
Tbx5 and Isl1 (arrowhead in F). (G) Anterior border of Hoxa3 expression is posterior to
Tbx5 and Isl1 regions. cc, cardiac crescent; SHF, second heart ﬁeld.mesoderm (compare Fig. 1D, F and I, arrowheads). As the heart tube
forms, Hoxb1 and Hoxa1 are expressed in both the splanchnic meso-
derm and the ventral and lateral foregut endoderm, but not in the
heart tube (Fig. 2A, C), as conﬁrmed by double in situ hybridization
with Isl1 (Supplemental Fig. S2). Double immunohistochemistry for
Hoxb1 and Isl1 revealed that Hoxb1 and Isl1-positive nuclei co-
localize in the caudal region of the SHF (Supplemental Fig. S3),
suggesting that Hoxb1 expression characterizes a sub-domain of the
Isl1+ splanchnic mesodermal population.
In order to examine the anterior boundaries of the expression of
theseHox geneswithin the splanchnicmesoderm,weusedMlc1v-nlacZ-
24 (Mlc1v-24) transgenic mice, in which a transgene integration at the
Fgf10 locus leads toβ-galactosidase expression in the anterior domainof
the SHF, referred to as the anterior heart ﬁeld (AHF) (Kelly et al., 2001).
We thus found that Hoxb1 transcripts and β-galactosidase activity
co-localize in the posterior half region of the AHF (Fig. 2A, B).
Co-localization of Hoxa1 expression and Mlc1-nlacZ-v24 staining is
more limited, since it is observed only in the most caudal margin of the
AHF (Fig. 2C, D), suggesting that the anterior limit of the expression
domain of Hoxa1 is within the posterior region of the AHF. In contrast,
Hoxa3 expression is not detected in the AHF but in splanchnic
mesoderm located posteriorly to the heart tube region (Fig. 2E, F).
Taken together, these results show that Hoxb1 andHoxa1 are expressed
in the SHFwith different anterior limits of expression within the caudal
AHF, while Hoxa3 is essentially expressed in the most caudal region of
the posterior SHF. Importantly, Hoxb1, Hoxa1 and Hoxa3 transcripts
were not detected in differentiated cardiomyocytes.Hoxb1-expressing cardiac progenitor cells contribute to the inferior wall
of the outﬂow tract
Recent evidence suggests that posterior SHF contributes to the
atria in mice (Cai et al., 2003; Galli et al., 2008), whereas the AHF gives
rise to the OFT and the right ventricle (Kelly et al., 2001; Zaffran et al.,
2004). Our in situ hybridization analysis suggests that Hoxb1+ cardiac
progenitor cells might thereby contribute to both the arterial and
venous poles of the heart. To investigate this question, we performed
genetic lineage tracing analysis of Hoxb1-expressing cells by crossing
aHoxb1IRES-Cre allele (Arenkiel et al., 2003) with the R26R-lacZ reporter
line (Soriano, 1999), which expresses β-galactosidase upon Cre
recombination. Until E7.75, the recombination pattern in lateral
mesoderm of Hoxb1IRES-Cre; R26R-lacZ embryos was highly similar to
the expression pattern of Hoxb1, including their anterior boundary
(Supplemental Fig. S4). At E8.5, however, the pattern of recombina-
tion in Hoxb1IRES-Cre; R26R-lacZ embryos was discordant with that of
Hoxb1 expression. Hoxb1, or Cre, transcripts were conﬁned to the SHF,
whereas β-galactosidase activity was found in the venous pole of the
heart (Supplemental Fig. S4). Between E9 and E16.5, Hoxb1 expression
was not detected in differentiated cardiomyocytes (data not shown),
whereas β-galactosidase activity was found in the majority of the atrial
cells and the atrioventricular canal (AVC) myocardium and its
derivatives, including the atrioventricular valves (Fig. 3A, C, G). X-gal
stained cells were found in the working myocardium of the left
ventricular free wall contiguous with AVC derivatives (Fig. 3G),
conﬁrming that the AVC lineage provides a contribution to this region
of the left ventricle (Aanhaanen et al., 2009). However, this contribution
is less important than the one observed for Tbx2+ progeny by
Aanhaanen et al. (2009). β-Galactosidase activity was also detected in
the epicardium (Fig. 3E–H) and subsequently in the walls of the main
coronary vessels (Fig. 3H; arrowhead). Because Raldh2 is strongly
expressed in the proepicardium (Moss et al., 1998; Xavier-Neto et al.,
1999) and RA signaling has an established function in the fetal
epicardium (Merki et al., 2005; Lin et al., 2010), we cannot exclude
later activation ofHoxb1 in this tissue. This contribution is also observed
in postnatal heart (data not shown).
Fig. 2. Hoxb1 and Hoxa1 expression patterns deﬁne distinct sub-domains within the second heart ﬁeld. (A–F) Lateral views of embryos at E8.5. (A, C, E) Whole-mount in situ
hybridization (ISH) analysis of Hoxb1 (A), Hoxa1 (C) and Hoxa3 (E) mRNAs. (B, D, F) Whole-mount ISH analysis of Hoxb1 (B), Hoxa1 (D) and Hoxa3 (F) genes combined with X-gal
staining for the Mlc1v-nlacZ-24 transgene, which marks the anterior heart ﬁeld (AHF). Dotted lines in A–F indicate the plane of sections in A1–F2. (A1–A3) Sections showing
expression of Hoxb1 in the medial (A2, arrowhead) and posterior (A3) domains of the second heart ﬁeld (SHF), and the absence of expression in the anterior domain of the SHF (A1).
Note the expression ofHoxb1 in the anterior foregut endoderm. (B1–B3) Sections showing co-localization of Hoxb1 and X-gal staining in the caudal region of the AHF (B2, B3) but not
in the anterior region of the AHF (B1). (C1–C3) Expression of Hoxa1 is only detected in the posterior region of the SHF (C3, arrowheads). Note the expression of Hoxa1 in the anterior
foregut endoderm (C2, C1). (D1–D3) Sections showing the co-localization of Hoxa1 and X-gal labeled cells only in the posterior region of the AHF (D3, arrowhead). (E1–E3) Hoxa3
expression is observed in the splanchnic mesoderm (E3, arrowhead) located posteriorly to the heart tube. (F1–F3) Sections showing that Hoxa3 is not detected in the AHF. cc, cardiac
crescent; en, endoderm; fg, foregut; ht, heart tube; SHF, second heart ﬁeld; sm, splanchnic mesoderm.
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observed in the arterial pole (Fig. 3B) and in the OFT of Hoxb1IRES-Cre;
R26R-lacZ embryos (Fig. 3D). X-gal labeled cells are detected
exclusively in the inferior wall of the OFT (Fig. 3D). Between E11.5
and E16.5, β-galactosidase activity is found in the left side of the OFT
wall and then in the myocardium at the base of the pulmonary trunk
(Fig. 3E, F, H), but not at the base of the aorta (Fig. 3I). This conﬁrms
that the myocardial wall of the OFT rotates as previously suggested
(Bajolle et al., 2006). Together, these ﬁndings indicate that precursors
of the inferior wall of the OFT, which contribute to the base of the
pulmonary trunk, segregate early in the SHF as proposed from a
previous study of regionalized transgene expression and retrospective
clonal analysis (Bajolle et al., 2008).
Our in situ hybridization analysis revealed a spatial difference
between Hoxb1, Hoxa1 and Hoxa3 transcripts in the SHF (Fig. 2). To
compare the contribution of Hoxa1- and Hoxa3-expressing cells with
the Hoxb1 lineage, we performed genetic lineage tracing using a
Hoxa1-enhIII-Cre transgene (Li and Lufkin, 2000) and a Hoxa3IRES-Cre
allele (Macatee et al., 2003). We used the 0.5 kb Hoxa1 enhancer III
because it was reported to recapitulate a signiﬁcant portion of the
Hoxa1 expression domain and to contain a functional RA regulatory
element (RARE) (Frasch et al., 1995). Until E8 to E9.5, the pattern of
recombination in Hoxa1-enhIII-Cre; R26R-lacZ embryos was highly
similar to the expression pattern of Hoxa1 (Supplemental Fig. S5). At
E9.5, X-gal staining revealed minimal difference to that seen with
Hoxa1IRES-Cre; R26R-lacZ embryos at the same stage (Supplemental Fig.
S5), as recently described (Makki and Capecchi, 2010). This supports
the use of the Hoxa1-enhIII-Cre transgene for our lineage analyses.
Between E10.5 and E16.5, descendants of cells expressing Hoxa1were
observed in a small number of atrial cells in Hoxa1-enhIII-Cre; R26R-
lacZ embryos (Fig. 4A–D). Of note, X-gal-labeled cells were never
found in the AVC in these embryos (data not shown), suggesting that
AVC myocytes are derived from the Hoxb1 lineage but not the Hoxa1lineage. As in Hoxb1IRES-Cre; R26R-lacZ hearts, X-gal-labeled cells in the
Hoxa1-enhIII lineage were located in the inferior wall of the OFT
(Fig. 4A, B). In contrast, β-galactosidase activity was only detected in
the distal OFT of Hoxa1-enhIII-Cre; R26R-lacZ embryos (Fig. 4A, B),
consistent with the small number of X-gal-labeled cells found later in
the myocardium at the base of the pulmonary trunk (Fig. 4C, D). At
E12.5, the Hoxa1-enhIII labeled cells were seen in the cushions of the
OFT (Fig. 4C), which probably corresponds to recombination in neural
crest cells.
Our Hoxa3+ lineage analysis conﬁrms that Hoxa3IRES-Cre recombi-
nation in the pharyngeal region begins at E8 in surface ectoderm
(Supplemental Fig. S5), and then extends into pharyngeal endoderm
and mesoderm (Macatee et al., 2003; Zhang et al., 2005). The
recombination pattern in Hoxa3IRES-Cre; R26R-lacZ embryos recapitu-
lated the caudal to rostral progression of Hoxa3 expression (Supple-
mental Fig. S1 and Fig. S5). Consistent with the other Hox lineages,
β-galactosidase activity was detected in the inferior myocardial wall
of the distal OFT of Hoxa3IRES-Cre; R26R-lacZ embryos (Fig. 4E, F).
Subsequently, X-gal staining was observed in myocardium at the base
of the pulmonary trunk (Fig. 4H). We also found X-gal labeled cells in
the OFT cushions (Fig. 4G). Together, our ﬁndings suggest that spatial
differences between Hoxb1, Hoxa1 and Hoxa3 observed in the
splanchnicmesoderm at E8.5 (Fig. 2) identify overlapping populations
of cardiac progenitor cells that contribute differentially to the
proximal and distal regions of the OFT (Figs. 3 and 4).
Reduction or excess of RA signaling alter the Hoxa1 and Hoxb1 lineages
The homeobox genes Hoxa1 and Hoxb1 are known to be RA-
regulated both in vitro and in vivo via RA-response elements (RAREs)
present in their regulatory regions (Marshall et al., 1996; Langston
et al., 1997; Studer et al., 1998; Niederreither et al., 1999; Huang
et al., 2002; Sirbu et al., 2005). Our Hoxa1 and Hoxb1 genetic lineage
Fig. 3. Genetic lineage analysis reveals a contribution ofHoxb1+ cardiac progenitors to the
atria and the myocardium at the base of the pulmonary trunk. (A–I) Hoxb1 lineage
visualized by X-gal staining of Hoxb1IRES-Cre; R26R-lacZ embryos. (A–C) Lateral views of
X-gal stained embryos at E9 (A, B) and E10.5 (C). (D–F) Ventral views of X-gal stained
hearts at E10.5 (D), E11.5 (E) and E14.5 (F). (G, I) Transverse sections of X-gal stained
hearts at E16.5. (A, B) X-gal staining showing a contribution of Hoxb1-positive cells to the
venous pole (left atrium) and arterial pole (white arrowhead) of Hoxb1IRES-Cre; R26R-lacZ
hearts. (C) Lateral viewof an E10.5X-gal stained embryo, showingβ-galactosidase activity
in the left atriumand the atrioventricular canal.Note that neural crest derivativespopulate
the secondbranchial arch (ba2). (D)Ventral viewofX-gal stainedheart fromHoxb1IRES-Cre;
R26R-lacZ embryo at E10.5. β-Galactosidase activity is detected in the left and right atria
but also in the outﬂow tract (OFT). Inset is a frontal section through stage E10.5 embryo,
showingβ-galactosidase activity only in the inferiorwall of theOFT. (E) Transverse section
of the heart from an E11.5 Hoxb1IRES-Cre; R26R-lacZ embryo. β-Galactosidase activity is
detected in the atria, theepicardium(arrowhead) and the left sideof theOFT. Inset shows a
ventral view of the same X-gal stained heart. (F) Ventral view of an X-gal stained heart at
E14.5, showing that labeled cells are detected in right and left atria and at the base of the
pulmonary trunk. Inset is a cranial view of the same heart. X-gal stained cells are
concentrated at the base of the pulmonary trunk. (G–I) Transverse sections of an E16.5
heart. β-Galactosidase activity is detected in the epicardium (arrowhead), the atrioven-
tricular valves and in themyocardiumat the base of the pulmonary trunk (arrow inH) but
not at thebase of the aorta (I). Arrow inG indicatesX-gal stained cells in the left ventricular
myocardium. Ao, aorta; avc, atrioventricular canal; ba, branchial arch; ep, epicardium; ht,
heart tube; la, left atrium; lb, limbbud; lv, left ventricle;mv;mitral valve; oft, outﬂowtract;
pt, pulmonary trunk; ra, right atrium; rv; right ventricle.
Fig. 4. Cardiac contribution of the Hoxa1-enhIII-Cre and Hoxa3IRES-Cre progeny. (A–D)
Hoxa1 lineage visualized by X-gal staining of Hoxa1-enhIII-Cre; R26R-lacZ embryos.
(E–H) Hoxa3 lineage visualized by X-gal staining of Hoxa3IRES-Cre; R26R-lacZ embryos.
Ventral views of X-gal stained hearts at E10.5 (A, E), E11.5 (G), E12.5 (C), E15.5 (H) and
E16.5 (D). (A, E) β-Galactosidase activity is detected in small number of left and right
atrial cells. X-gal staining is observed in the distal outﬂow tract (OFT) in Hoxa1-enhIII-
Cre; R26R-lacZ and Hoxa3IRES-Cre; R26R-lacZ embryos. Insets show cranial views of the
same hearts conﬁrming β-galactosidase activity in the inferior wall of the OFT. (B, F)
Sagittal sections of embryos at the same stage showing X-gal labeled cells in the inferior
wall of the OFT. (C, D) Ventral views of X-gal stained hearts at E12.5 and E16.5.
β-Galactosidase activity is detected in both atria and in the myocardium at the base of
the pulmonary trunk. Inset in C displays X-gal labeled cells in the OFT cushions. (G, H)
Ventral views of X-gal stained hearts at E11.5 and E15.5, showing that few labeled cells
are detected in the left side of the OFT (arrowhead) and later in the myocardium at the
base of the pulmonary trunk. Inset in G reveals X-gal labeled cells in OFT cushions. Inset
in H shows a ventral view of stronger X-gal stained heart at the same stage. Ao, aorta;
b, branchial arch; g, gut epithelium; ht, heart tube; la, left atrium; lb, limb bud; oft,
outﬂow tract; pt, pulmonary trunk; ra, right atrium; rv; right ventricle.
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recently described by Dolle et al. (2010) and Li et al. (2010). This
raises the possibility that a deﬁciency in RA biosynthesis might affect
the Hox lineages. To address this question, we examined Hoxa1 and
Hoxb1 expression patterns in embryos deﬁcient in RA synthesis. We
found that expression of Hoxa1 and Hoxb1, as well as Hoxa3, are
downregulated in the splanchnic mesoderm at E8.5 in Raldh2−/−
embryos (Supplemental Fig. S6). We next examined Hoxb1IRES-Cre
and Hoxa1-enhIII-Cre lineages in Raldh2−/− embryos. At E8.5 and
E9.5, there is no X-gal staining in Hoxa1-enhIII-Cre; R26R-lacZ;
Raldh2−/− embryos (Fig. 5A–C). This observation supports the
importance of signaling through the RA regulatory element (RARE)
present in Hoxa1 enhancer III (Frasch et al., 1995; Li and Lufkin,
2000). In contrast to the Hoxa1-enhIII-Cre lineage, β-galactosidase
positive cells were still detected in Hoxb1IRES-Cre; R26R-lacZ;
Raldh2−/− embryos (Fig. 5D-F), suggesting that early expression of
Hoxb1 in cardiac progenitor cells may not be activated by RA
signaling. However, sections show that β-galactosidase activity was
also not visible in the ectoderm of Raldh2−/− embryos (Fig. 5E, F),
revealing tissue-speciﬁc sensitivity to RA signaling. Although theHoxb1IRES-Cre lineage was detectable in Raldh2−/−mutant hearts, we
believe that incorporation of X-gal labeled cells into the heart tube
may be a consequence of the lack of the dorsal closure of the heart
tube rather than a normal addition process at both the arterial and
venous poles (Fig. 5F).
To determine whether Hox lineages are sensitive to increased RA
signaling, we treated the mothers of Hoxa1-enhIII-Cre; R26R-lacZ and
Hoxb1IRES-Cre; R26R-lacZ embryos with a teratogenic dose of RA to
disrupt the normal boundary of RA activity (Niederreither et al., 1999;
Sirbu et al., 2005). When we administrated a 70 mg/kg dose of RA at
E7.75, we conﬁrmed the anterior shift of the rostral border of Hoxa1,
Hoxb1 and Hoxa3 expression domains, including in the pharyngeal
mesoderm (Supplemental Fig. S6). Consistently, comparison of
control and RA-treated Hoxb1IRES-Cre; R26R-lacZ embryos demonstrat-
ed that the Hoxb1IRES-Cre lineage is responsive to RA (Fig. 5I, J).
Importantly, X-gal labeled cells were found in the forming heart tube
(Fig. 5J, J'), suggesting that the anterior boundary of RA activity
deﬁnes the location of theHoxb1IRES-Cre lineage boundary. Effect of RA-
Fig. 5. Reduction or excess of RA signaling causes abnormalities of Hoxa1+ and Hoxb1+
cardiac progenitors contribution. (A–J) Lateral views of E8.5 (A, B, G–J), E8.75 (D–F) and
E9.5 (C) embryos. (A–C) β-galactosidase activity is detected in Hoxa1-enhIII-Cre; R26R
embryo,whereas no X-gal labeled cells are observed inHoxa1-enhIII-Cre; R26R; Raldh2−/−
mutant embryos, which reveals the requirement of retinoic acid (RA) for the induction of
this transgene. (D, E) Lateral view of X-gal stained Hoxb1IRES-Cre; R26R-lacZ embryos at
E8.75. (F) Transverse section of the embryo shown in E at the heart tube level. Inset in D
shows a similar transverse section in the control embryo. X-gal labeled cells are yet
detected in Raldh2−/− (E, F) mutant embryo. (F) Sections conﬁrm that dorsal
mesocardium is not closed in mutant embryos (brackets). Note the absence of X-gal
staining in the surface ectoderm (arrowhead), suggesting differential response to
deﬁciency in RA signaling. (G, H) X-gal staining showing increased activity of Hoxa1-
enhIII-Cre transgene (arrows) in the anterior domain of RA-treated embryos. (H') Sagittal
section of the embryo in H showing X-gal labeled cells in the heart tube (arrowhead). (I, J)
X-gal staining showing increase of Hoxb1IRES-Cre in Hoxb1IRES-Cre; R26R-lacZ embryos
treated with all-trans-RA. (J') Sagittal section exhibits β-galactosidase activity in the heart
tube (arrowhead) of the embryo shown in J. ht, heart tube.
Fig. 6. Reduction of RA signaling induces defect of the inferior wall of the outﬂow tract.
(A, B) X-gal staining showing absence of y96-Myf5-nlacZ-16 (96–16) transgene expression
in Raldh2−/− (B) embryos at E9.5. (C, D) At E9.5, β-galactosidase activity is detected in
the superior wall of the heart tube of A17-Myf5-nlacZ-T55 (T55); Raldh2−/− (D) embryos.
ht, heart tube; lv, left ventricle; oft, outﬂow tract; rv, right ventricle.
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(Fig. 5G, H), suggesting that the RARE within enhancer III-Cre
transgene is less sensitive than in the context of the endogenous
Hoxa1 promoter. When a 85 mg/kg dose of RA was injected at E8.5 in
Hoxa3IRES-Cre; R26R-lacZ embryos, only few X-gal labeled cells were
found anterior to the otic vesicle and in the ﬁrst branchial arch
(Supplemental Fig. S7), suggesting that RA has a restricted effect on
the activation of the Hoxa3 lineage after E8.
Our previous and present results showed that RA is required for
correct deployment of the SHF (Ryckebusch et al., 2008). In addition, a
recent study suggested that formation of the OFT is disrupted in RA
receptormutant embryos, resulting in a short,misalignedOFT (Li et al.,
2010). To further explore the role of RA signaling onOFT formation,we
compared the expression of y96-Myf5-nlacZ-16 (96–16) and A17-
Myf5-nlacZ-T55 (T55) transgenes (Bajolle et al., 2006; Bajolle et al.,
2008), which have complementary patterns in the OFT, in Raldh2−/−
mutant embryos. Interestingly, the domain of expression of the 96–16
transgene corresponded to theβ-galactosidase activity observed in the
OFT in Hoxb1IRES-Cre; R26R-lacZ embryos (Fig. 6A and 3D). Thus, wefound that the sub-domain of 96–16 transgene expressing cells is
missing in the RA deﬁcient embryos (Fig. 6A, B), whereas cells
expressing the T55 transgenewere still present in theOFTofRaldh2−/−
mutant hearts (Fig. 6C, D). These results suggest that only a sub-
domain of the OFT is affected in Raldh2−/− mutant embryos. We
presume that perturbation of RA signaling causes a failure in the
deployment of the Hoxb1-expressing cardiac progenitor cell subpop-
ulation during the formation of the OFT.
Discussion
Anterior-posterior patterning of the SHF in the mouse
Previous expression and genetic lineage studies indicated that the
majority of cardiac components (outﬂow tract [OFT], right ventric-
ular and atrial myocardium) are derived from an Isl1+ splanchnic
mesodermal cell population, called the second heart ﬁeld (SHF) (Cai
et al., 2003; Ma et al., 2008). The question of the early spatial
segregation of cardiac progenitor cells is crucial to understand their
speciﬁcation in precardiac mesoderm and subsequent fate in the
heart. There is increasing evidence for the existence of cardiac
progenitor sub-populations in the SHF, such as the anterior region of
the SHF (also called AHF and marked by expression of Fgf10) (Kelly
et al., 2001), which contributes to right ventricular and OFT
myocardium (Zaffran et al., 2004), whereas the posterior SHF,
which expresses Isl1 but not Fgf10, contributes to atrial myocardium
(Cai et al., 2003; Galli et al., 2008). These observations indicate that at
least two sub-compartments are positioned along the AP axis within
the SHF. Our data reveal that expression of Hox genes characterizes
distinct progenitor cell sub-domains within the SHF. These results
suggest that regionalized expression of Hoxb1 and Hoxa1 in
splanchnic mesoderm may be required to establish AP patterning
of the SHF. Furthermore, our genetic lineage tracing analysis shows
that Hoxb1, Hoxa1 and Hoxa3 lineages contribute to both the arterial
and venous poles of the heart (Fig. 7). Contribution of Hoxa1 and
Hoxa3 lineages to the OFT supports the idea that posterior SHF cells
might contribute the arterial pole of the forming heart tube.
Interestingly, we observed a difference in the contribution of Hox
lineages to the proximo-distal region of the OFT and atria;
descendants of cells expressing Hoxb1 are found in the proximal
OFT and atria, while descendants of cells expressingHoxa1 andHoxa3
are observed only in the distal OFT and in discrete regions of the atria.
These results indicate that segregation among cardiac progenitor
Fig. 7.Model for cardiac contributions of progenitor cells expressing Hox genes in the second heart ﬁeld. Genetic lineage analysis wasmade with Hoxb1Cre, Hoxa1-EnhIII-Cre, Hoxa3Cre
and R26R-lacZ lines. X-gal stained cells are represented by blue colors. The location of the second heart ﬁeld (SHF) is shown in green. Frontal view is shown for embryonic day 7.5
(E7.5) and lateral view for E8.5. Early Hoxb1/a1/a3 expressing cells characterize distinct sub-domains along the antero-posterior axis in the SHF. Later, these cardiac progenitor cells
contribute to both atria and the inferior wall of the OFT, which subsequently gives rise to myocardium at the base of pulmonary trunk. Ao, aorta; CC, cardiac crescent; ep, epicardium;
ht, heart tube; LA, left atria; Pt, pulmonary trunk; RA, right atria; r4, rhombomere 4.
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poles of the heart. Interestingly, retrospective clonal analysis in the
heart at E8.5 has identiﬁed clones that can contribute to regions of
both the future atria and OFT (Meilhac et al., 2004). Thus, we believe
that these clones are born from Hoxb1+ progenitor cells.
Hox genes have been proposed to be the key downstream effectors
of RA signaling during cardiac development (reviewed in (Rosenthal
and Xavier-Neto, 2000)). This is supported by recent studies in
zebraﬁsh, which identiﬁed Hoxb5b as a downstream target of RA
signaling that restricts the numbers of both atrial and ventricular cells
that emerge from the heart ﬁeld (Waxman et al., 2008) and showed
that injection of Hoxb5b mRNA phenocopies RA treatment, which
consists in the loss of both atrial and ventricular cardiomyocytes
(Waxman and Yelon, 2009). Waxman et al. have shown that
reduction of RA signaling does not lead to an increase in ventricular
cells at the expense of the atrial lineage (Waxman et al., 2008). These
observations are not consistent with a role for RA signaling in
partitioning the heart tube, as suggested by previous studies in
amniotes (Yutzey et al., 1994; Hochgreb et al., 2003; Ryckebusch et al.,
2008; Sirbu et al., 2008). Indeed, treatment of chick embryos with a
RA pan-antagonist produces a heart with reduction of the atrial
compartment and an oversized ventricle (Hochgreb et al., 2003),
while RA deﬁciency mouse embryos have impaired atrial and sinus
venosus development (Niederreither et al., 2001), as well as loss of
the inferior wall of the OFT (this study). We have shown that
manipulation of RA signaling affects the rostral boundaries of Hoxa1,
Hoxb1 and Hoxa3 expression in the SHF. Therefore, RA may control AP
patterning of the SHF through the tight regulation of the expression of
these Hox genes in splanchnic mesoderm. The question of the role of
anterior Hox genes in the SHF can only be determined by inactivating
and overexpressing these genes in their respective precursor popula-
tions. Of note, no abnormality in the heart of Hoxa1 and Hoxb1mutant
mice have been reported (Lufkin et al., 1991; Carpenter et al., 1993;
Goddard et al., 1996; Studer et al., 1996), but non-lethal cardiovas-
cular morphological defects may not have been examined in detail.
Moreover, Hoxa1 and Hoxb1 have been shown to function together in
several structures including the hindbrain, cranial nerves and second
pharyngeal arch (Gavalas et al., 1998; Studer et al., 1998; Rossel and
Capecchi, 1999). Hence, characterization of cardiac defects in double
Hoxa1;Hoxb1 homozygous mutant embryos will be essential.Contribution of Hox lineages to the outﬂow tract of the heart
Diverse subpopulations of the SHF have been deﬁned in the mouse
and chick. These include the anterior heart ﬁeld (AHF), giving rise to
all OFT myocardium, and the “secondary” heart ﬁeld, situated in the
dorsal pericardial wall giving rise to myocardium of the distal OFT
(Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al., 2001). Our
results indicate that the splanchnic mesodermal cells expressing
Hoxa1 are part of the murine “secondary” heart ﬁeld. Surprisingly, our
ﬁndings show that cardiac progenitor cells expressing Hoxb1, Hoxa1
and Hoxa3 contribute to sub-pulmonary myocardium but not
myocardial cells at the base of the aorta. This is consistent with
observations on the clustering of clonally related cells in the OFT
(Bajolle et al., 2008), which had suggested that future sub-pulmonary
myocardium is pre-patterned in distinct sub-domains of progenitor
cells. Future sub-aortic myocardial progenitor cells are positioned
anterior to future sub-pulmonary progenitor cells in the SHF.
Interestingly, the contribution ofHoxb1-expressing cardiac progenitor
cells to the OFT is very similar to that of Tbx1Cre at E10.5 (Huynh et al.,
2007). Deletion of Tbx1, the major candidate gene for DiGeorge
syndrome, results in a persistent truncus arteriosus (PTA) (Baldini,
2005), and sub-pulmonary myocardium is speciﬁcally affected in
Tbx1 mutant hearts (Theveniau-Ruissy et al., 2008). Thus, it will be
of interest to explore the contribution of the Hoxb1 lineage in the
absence of Tbx1.
Studies on RA receptors (RARα1/RARβ ) and Raldh2 mutant
embryos have demonstrated the importance of RA signaling during
OFT development (Lee et al., 1997; Niederreither et al., 2001; Jiang
et al., 2002; Li et al., 2010). Interestingly, results from RAR mutants
imply that proximal and distal domains of the OFT are pre-patterned
in the splanchnic mesoderm (Li et al., 2010), consistent with the
differential AP expression of Hoxb1, Hoxa1 and Hoxa3 in the SHF, and
their different contributions to the OFT. Thus, we hypothesize that the
SHF is patterned from anterior to posterior, as follows: cells giving rise
to the right ventricle and superior wall of the OFT (Hox-negative
cells), to the inferior wall of the proximal OFT (Hoxb1-positive cells),
to the inferior wall of the distal OFT (Hoxb1 and Hoxa1-positive cells),
and, most posteriorly, to atrial myocardium. Analysis of RA synthesis
and RA response suggest that RA signaling acts predominantly in SHF
cells characterized by Hoxb1 expression (Moss et al., 1998; Hochgreb
273N. Bertrand et al. / Developmental Biology 353 (2011) 266–274et al., 2003; Ryckebusch et al., 2008; Sirbu et al., 2008; Dolle et al.,
2010). This is supported by analysis of Raldh2 and RA receptor
mutants in which derivatives of Hoxb1+ sub-domains as described
above are lacking (Ryckebusch et al., 2008; Li et al., 2010 and this
study). OFT defects observed in RA receptor mutants as well as in RA-
rescued Raldh2 mutants, suggest that RA signaling acts from E7.5 to
E10.5 to allow correct deployment of Hoxb1+ progenitor cells
(Niederreither et al., 2001; Li et al., 2010). Works performed on
Raldh2−/− mutants have shown that RA signaling is required ﬁrst to
determine the posterior limit of the SHF as posterior expansion of SHF
markers is observed as soon as E7.5 (Ryckebusch et al., 2008; Sirbu
et al., 2008). Maternal RA supplementation experiments reveal a
further requirement of RA until E10.5 that we believe is associated
with contribution of Hoxb1+ progenitor cells to the heart tube
(Niederreither et al., 2001). RA could allow this contribution through
controlling speciﬁcation, differentiation and/ormigration of those SHF
cells. With respect to absent septation and misalignments of the OFT
including PTA, double outlet right ventricle (DORV) and overriding
aorta observed in RA receptor and RA-rescued Raldh2mutant embryos
(Niederreither et al., 2001; Li et al., 2010), we speculate that lack of the
inferior wall of the OFT, a derivative of particular Hoxb1+ progenitor
cells, may be sufﬁcient to lead to these defects. Of course, the latter
speculation does not exclude a potential role of RA signaling on cardiac
NCC (Niederreither et al., 2001; Jiang et al., 2002).
In human congenital heart disease, OFT alignment defects, such as
tetralogy of Fallot, are frequent and may result from a deﬁcit in sub-
pulmonary myocardium (Van Praagh, 2009). It is interesting to note
that recent studies in humans have identiﬁed homozygous HOXA1
coding mutations in patients with OFT defects, including tetralogy of
Fallot (Tischﬁeld et al., 2005; Bosley et al., 2008). Together with our
present results, these observations should lead to further investiga-
tions into the causative role of HOX mutations in the pathogenesis of
heart and great vessels malformations in humans.
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